BPC-157 — Research Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids originally isolated from human gastric juice. This compound has been studied extensively in laboratory settings for its pleiotropic effects across multiple biological systems, making it one of the more broadly researched peptides in regenerative and systemic healing studies. Laboratory research has examined its interactions with VEGF signaling pathways, growth factor receptors, nitric oxide pathways, and serotonergic and dopaminergic systems. Available from 4-LD in 5mg and 10mg lyophilized form, BPC-157 is produced under quality-controlled conditions exclusively for qualified researchers and laboratory professionals conducting in-vitro research.

Areas of Active Research

BPC-157 has been studied across several active research areas. In musculoskeletal research, animal models have examined its effects on collagen synthesis, tendon and ligament healing, extracellular matrix remodeling, and bone repair in fracture models. In gastrointestinal research, studies have investigated its cytoprotective effects on gastric mucosa, its potential role in reducing ulceration in NSAID models, and its influence on tight junction proteins associated with intestinal barrier function in colitis models. In neurological research, preclinical studies have explored its potential to reduce glutamate excitotoxicity, support dopamine neuron preservation in Parkinson's models, and accelerate axonal growth in peripheral nerve injury studies. In systemic healing research, its interactions with VEGF, nitric oxide pathways, and growth factor receptors have been studied for their potential role in vascularization and tissue repair across multiple organ systems. All findings referenced are from preclinical and in-vitro studies. This product is intended solely for laboratory research by qualified professionals and is not for human or animal consumption. 4-LD makes no therapeutic claims regarding this compound.